Navigation Links
The Apothecary Shops Receives Exclusive Distribution Rights for Mitosol®
Date:2/17/2012

PHOENIX, Feb. 17, 2012 /PRNewswire-iReach/ -- Apothecary Shop Wholesale, Inc., an affiliate of The Apothecary Shops Specialty Pharmacies, has received exclusive distribution rights from Mobius Therapeutics, LLC for its new drug Mitosol® (mitomycin for solution) 0.2 mg/vial Kit for Ophthalmic Use.

The Mitosol® Kit for Ophthalmic Use provides ophthalmic surgeons a new means of delivering a precise dose of its active ingredient, mitomycin-c, for use in glaucoma surgical procedures, without requiring a change to existing surgical technique.   Last week, Mitosol® was approved by the Food and Drug Administration for use in as an antimetabolite indicated  as an adjunct to ab externo glaucoma surgery. ( See full prescribing information at  )

"The approval of Mitosol® for use in glaucoma surgery represents the culmination of years of work on the part of Mobius Therapeutics™," said Ed Timm, President of Mobius Therapeutics™.  "It will provide surgeons, hospitals and patients with enhanced convenience, safety and consistency in the surgical treatment of glaucoma."

Since opening its first location in Arizona in 1996, The Apothecary Shops has focused on specific disease states, including ophthalmology, and has vast experience in providing medications for patients with eye-related illnesses and diseases.  To best serve their patients, The Apothecary Shops has a dedicated ophthalmology sales and pharmacist team, VAWD Accreditation, and a wholesale division for office ordering.

"The Apothecary Shops is the ideal partner to distribute Mitosol®," said Ed Timm, President and CEO of Mobius Therapeutics.  "Their expertise and deep understanding of ophthalmology combined with exceptional customer service levels gives us great confidence in their ability to provide the market an uninterrupted source of supply and a superior customer experience."

"We're proud to be selected by Mobius Therapeutics as the exclusive distribution partner for this very important new drug, and better serve our customers", said Sheri Garver, Apothecary Shop Wholesale Director.

Glaucoma is the second-leading cause of blindness in the United States; it is incurable and loss of vision is irreversible.  Once diagnosed, medication and/or surgery may halt further loss of vision.  Although often thought of as a disease that affects the elderly, glaucoma strikes people of all ages.  The best way to protect your sight from glaucoma is to get tested, and if diagnosed, begin treatment immediately. (Source: Glaucoma Resource Foundation website, February, 2012)

About The Apothecary Shop Wholesale, Inc.

Apothecary Shop Wholesale is a VAWD accredited wholesaler affiliated with a national specialty pharmacy, The Apothecary Shops, which has provided individualized care and support to patients since 1996.  Specialties include ophthalmology, oncology, infectious diseases, including HIV/AIDS and hepatitis, fertility, pain management, women's health, and transplant-related medicines.  The Apothecary Shops' clinical pharmacists and staff members are experts in managing complex disease states and providing compassionate care. The Apothecary Shops offer a nationwide specialty national distribution service to complement 16 physical locations. For more information, visit: www.theapothecaryshop.com.

About Mobius Therapeutics, LLC

Mobius Therapeutics, LLC is a St. Louis-based commercial stage venture focused on ophthalmic surgery solutions.  Its first product, Mitosol®, is a system for delivering antifibrotic agents in glaucoma, refractive, and corneal surgery.   The glaucoma indication is in active commercialization; the refractive and corneal indications are awaiting approval by the Food and Drug Administration. For more information, visit: www.mobiustherapeutics.com.

Media Contact:

Jackie Wright Rainmaker Integrated, 480-361-4348, jackie@rmimpr.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE Apothecary Shop Wholesale, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Nyer Medical Group, Inc., Announces Agreements to Sell Certain Eaton Apothecary Assets to Walgreens and Sell Operating Subsidiarys Stock to Investors
2. The Apothecary Shops Incorporates Innovative Technology Into Patient Medication Reminders
3. FDA: Orphan Drug Workshops Scheduled For Feb. 25-26 and Aug. 3-4, 2010
4. BioStorage Technologies to Sponsor and Present Educational Workshops at Annual Biorepositories Conference
5. Medical Device Conference Opens October 18, 2010 With Free Executive Workshops; Full Conference Highlights Latest Industry Trends, Technology Innovations and Keynote Speeches by the U.S. FDA Commissioner, U.S. CMS Administrator, CBS Evening News Anc
6. AdvaMed 2010 Premier Medical Technology Conference Opens Today in Washington D.C. With Executive Workshops, Company Presentations, Innovation Alley Exhibits and Featured Keynote Speakers: FDA Commissioner Dr. Margaret Hamburg, CMS Administrator Dr.
7. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
8. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
9. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
10. Abbott Receives Supplemental FDA Approval for its Best-in-Class in Sensitivity RealTime HIV-1 Viral Load Test
11. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/5/2017)... Ill. , Oct. 5, 2017  In ... Association of Oral and Maxillofacial Surgeons (AAOMS) released ... opioids – to be used as a first-line ... pain. Recognizing ... the AAOMS White Paper "Opioid Prescribing: Acute and ...
(Date:10/2/2017)... -- Eli Lilly and Company (NYSE: LLY ) ... of 2017 on Tuesday, October 24, 2017. Lilly will ... the investment community and media to further detail the ... begin at 9 a.m. Eastern time. Investors, media and ... the conference call through a link that will be ...
(Date:9/28/2017)... 28, 2017 Cohen Veterans Bioscience and Early ... of wearable and home sensors for real-time monitoring of ... Foundation, a nonprofit organization focused on disruptive health solutions ... affordable analytical system to record and integrate behavioral, cognitive, ... ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer ... one of the most popular and least understood books in the Holy Scriptures, Revelation. ... descriptions that have baffled scholars for centuries. Many have tossed it off as mere ...
(Date:10/13/2017)... ... 13, 2017 , ... “The Journey: From the Mountains to the Mission Field”: ... souls in the Philippines. “The Journey: From the Mountains to the Mission Field” is ... Bible. She has taught all ages and currently teaches a class of ladies at ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and San Francisco dentists, ... cutting-edge Oventus O2Vent technology. As many as 18 million Americans are estimated to ... breathing. Oral appliances can offer significant relief to about 75 percent of people ...
(Date:10/12/2017)... ... October 12, 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ... the introduction of an innovative new design of the shoulder pad. The shoulder ... maximum comfort while controlling your pain while using cold therapy. By utilizing ice and ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... delivery system that we intend to develop to enable prevention of a major ... to severe hearing loss, especially in pediatric patients. For cisplatin, hearing loss is ...
Breaking Medicine News(10 mins):